SCHEMBL985733

SCHEMBL985733

COCC(=O)N[C@H]1CC[C@@H](NC(=O)c2c[nH]c3c(-c4ccc(F)cc4OCC4CC4)ncnc23)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 1/20 0.40
GRIN1 Q05586 1/20 0.38
GRIN2B Q13224 1/20 0.38
LMNA P02545 1/20 0.36
KDM5A P29375 1/20 0.36
KDM4C Q9H3R0 1/20 0.36
HTR2A P28223 3/20 0.35
DRD3 P35462 3/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
ACACB O00763 1/20 0.35
CRHR1 P34998 2/20 0.35
PRKACA P17612 1/20 0.35
PRKACG P22612 1/20 0.35
PRKACB P22694 1/20 0.35
HPGD P15428 1/20 0.35
ALDH1A1 P00352 1/20 0.35
KMT2A Q03164 1/20 0.35
PHF8 Q9UPP1 3/20 0.34
KDM2B Q8NHM5 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL985542 1.00 BTK (0.40) BTKGRIN1GRIN2BLMNAKDM5A
SCHEMBL984334 0.95 BTK (0.39) BTKGRIN1GRIN2BLMNAHTR2A
SCHEMBL984888 0.92 KDM4E (0.42) BTKGRIN1GRIN2BRAB9AACACB
SCHEMBL983455 0.92 KDM4E (0.42) BTKGRIN1GRIN2BRAB9AACACB
SCHEMBL984894 0.91 GRIN1 (0.36) GRIN1GRIN2BLMNAKDM5AKDM4C
SCHEMBL985885 0.91 GRIN1 (0.36) GRIN1GRIN2BLMNAKDM5AKDM4C
SCHEMBL983145 0.91 BTK (0.44) BTKNPC1RAB9AHPGDALDH1A1
SCHEMBL986391 0.90 CDK9 (0.41) BTKGRIN1GRIN2BKDM5AKDM4C
SCHEMBL985350 0.90 CDK9 (0.41) BTKGRIN1GRIN2BKDM5AKDM4C
SCHEMBL983530 0.89 BTK (0.40) BTKKDM5AKDM4CKMT2APHF8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2011-01-27 US claimed
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2011-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES PDE5A, PDE3A, PDE2A BTK 1977/4885GRIN1 2493/4885GRIN2B 2516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.